Katherine R. Calvo, Ph.D. - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 

67/170 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Manasanch EE, de Larrea CF, Zingone A, Steinberg SM, Kwok M, Tageja N, Bhutani M, Kazandjian D, Roschewski M, Wu P, Carter G, Zuchlinski D, Mulquin M, Lamping L, Costello R, ... ... Calvo KR, et al. Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone. Leukemia & Lymphoma. 1-10. PMID 27687480 DOI: 10.1080/10428194.2016.1214953  0.88
2016 Cohen JI, Dropulic L, Hsu AP, Zerbe CS, Krogmann T, Dowdell K, Hornung RL, Lovell J, Hardy N, Hickstein D, Cowen EW, Calvo KR, Pittaluga S, Holland SM. Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27169477 DOI: 10.1093/cid/ciw160  0.88
2016 Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, Ganson NJ, Hershfield MS, Holland SM, Hickstein DD. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation. The Journal of Allergy and Clinical Immunology. PMID 27130863 DOI: 10.1016/j.jaci.2016.03.016  0.88
2016 Kuehn HS, Boisson B, Cunningham-Rundles C, Reichenbach J, Stray-Pedersen A, Gelfand EW, Maffucci P, Pierce KR, Abbott JK, Voelkerding KV, South ST, Augustine NH, Bush JS, Dolen WK, Wray BB, ... ... Calvo KR, et al. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS. The New England Journal of Medicine. 374: 1032-1043. PMID 26981933 DOI: 10.1056/NEJMoa1512234  0.88
2016 Skarzynski M, Niemann CU, Lee YS, Martyr S, Maric I, Salem D, Stetler-Stevenson M, Marti GE, Calvo KR, Yuan C, Valdez J, Soto S, Farooqui MZ, Herman SE, Wiestner A. Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 22: 86-95. PMID 26283682 DOI: 10.1158/1078-0432.CCR-15-1304  0.88
2015 Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski M, Mulquin M, Carpenter A, Lamping E, Minter AR, Weiss BM, Mena E, ... ... Calvo KR, et al. Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: A prospective study using functional and morphologic imaging. Leukemia & Lymphoma. 1-23. PMID 26690712 DOI: 10.3109/10428194.2015.1090572  0.88
2015 Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, Martyr S, Stetler-Stevenson M, Yuan CM, Calvo KR, Braylan RC, Valdez J, Lee YS, Jones J, Wong DH, et al. Disruption of in vivo chronic lymphocytic leukemia tumor-microenvironment interactions by ibrutinib - findings from an investigator initiated phase 2 study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26660519 DOI: 10.1158/1078-0432.CCR-15-1965  0.88
2015 Wang W, Corrigan-Cummins M, Barber EA, Saleh LM, Zingone A, Ghafoor A, Costello R, Zhang Y, Kurlander RJ, Korde N, Roccaro AM, Ghobrial IM, Landgren O, Calvo KR. Aberrant Level of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression. The Journal of Molecular Diagnostics : Jmd. PMID 26433312 DOI: 10.1016/j.jmoldx.2015.06.006  0.88
2015 Landgren O, Shim YK, Michalek J, Costello R, Burton D, Ketchum N, Calvo KR, Caporaso N, Raveche E, Middleton D, Marti G, Vogt RF. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study. Jama Oncology. PMID 26335650 DOI: 10.1001/jamaoncol.2015.2938  0.88
2015 Korde N, Roschewski M, Zingone A, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Wu P, Morrison C, Costello R, Zhang Y, Burton D, Mulquin M, ... ... Calvo KR, et al. Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma. Jama Oncology. PMID 26181891 DOI: 10.1001/jamaoncol.2015.2010  0.88
2015 Niemela J, Kuehn HS, Kelly C, Zhang M, Davies J, Melendez J, Dreiling J, Kleiner D, Calvo K, Oliveira JB, Rosenzweig SD. Caspase-8 Deficiency Presenting as Late-Onset Multi-Organ Lymphocytic Infiltration with Granulomas in two Adult Siblings. Journal of Clinical Immunology. 35: 348-55. PMID 25814141 DOI: 10.1007/s10875-015-0150-8  0.88
2015 Lozier JN, Calvo KR. Effect of viral decontamination measures on Wright-stained blood smears. Blood. 125: 1350-1. PMID 25700425 DOI: 10.1182/blood-2014-12-614701  0.88
2015 Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, Rao VK. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 125: 2753-8. PMID 25691160 DOI: 10.1182/blood-2014-11-567917  0.88
2015 Montezuma-Rusca JM, Moir S, Kardava L, Buckner CM, Louie A, Kim LJ, Santich BH, Wang W, Fankuchen OR, Diaz G, Daub JR, Rosenzweig SD, Chun TW, Li Y, Braylan RC, ... Calvo KR, et al. Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals. Journal of Immunology (Baltimore, Md. : 1950). 194: 2561-8. PMID 25681347 DOI: 10.4049/jimmunol.1402424  0.88
2015 Goswami M, McGowan KS, Lu K, Jain N, Candia J, Hensel NF, Tang J, Calvo KR, Battiwalla M, Barrett AJ, Hourigan CS. A multigene array for measurable residual disease detection in AML patients undergoing SCT. Bone Marrow Transplantation. 50: 642-51. PMID 25665046 DOI: 10.1038/bmt.2014.326  0.88
2015 McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Bryke CR, Hsu N, Dai Z, Marquesen MM, Stregevsky E, Kwatemaa N, Theobald N, ... ... Calvo KR, et al. Chromothriptic cure of WHIM syndrome. Cell. 160: 686-99. PMID 25662009 DOI: 10.1016/j.cell.2015.01.014  0.88
2015 Farooqui MZ, Valdez J, Martyr S, Aue G, Saba N, Niemann CU, Herman SE, Tian X, Marti G, Soto S, Hughes TE, Jones J, Lipsky A, Pittaluga S, Stetler-Stevenson M, ... ... Calvo KR, et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. The Lancet. Oncology. 16: 169-76. PMID 25555420 DOI: 10.1016/S1470-2045(14)71182-9  0.88
2015 Ganapathi KA, Townsley DM, Hsu AP, Arthur DC, Zerbe CS, Cuellar-Rodriguez J, Hickstein DD, Rosenzweig SD, Braylan RC, Young NS, Holland SM, Calvo KR. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 125: 56-70. PMID 25359990 DOI: 10.1182/blood-2014-06-580340  0.88
2015 Manasanch EE, Salem DA, Yuan CM, Tageja N, Bhutani M, Kwok M, Kazandjian D, Carter G, Steinberg SM, Zuchlinski D, Mulquin M, Calvo K, Maric I, Roschewski M, Korde N, et al. Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: Influence of biopsy site and anticoagulation method Leukemia and Lymphoma. 56: 1416-1424. DOI: 10.3109/10428194.2014.955020  0.88
2015 Ganapathi KA, Schafernak KT, Rao VK, Calvo KR. Pediatric myelodysplastic/myeloproliferative neoplasms and related diseases Journal of Hematopathology. 8: 159-167. DOI: 10.1007/s12308-015-0250-7  0.88
2014 Grossman J, Cuellar-Rodriguez J, Gea-Banacloche J, Zerbe C, Calvo K, Hughes T, Hakim F, Cole K, Parta M, Freeman A, Holland SM, Hickstein DD. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1940-8. PMID 25111582 DOI: 10.1016/j.bbmt.2014.08.004  0.88
2014 Zingone A, Wang W, Corrigan-Cummins M, Wu SP, Plyler R, Korde N, Kwok M, Manasanch EE, Tageja N, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Roschewski M, Zhang Y, ... ... Calvo KR, et al. Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease. Cytokine. 69: 294-7. PMID 25043675 DOI: 10.1016/j.cyto.2014.05.017  0.88
2014 Sadat MA, Moir S, Chun TW, Lusso P, Kaplan G, Wolfe L, Memoli MJ, He M, Vega H, Kim LJ, Huang Y, Hussein N, Nievas E, Mitchell R, Garofalo M, ... ... Calvo KR, et al. Glycosylation, hypogammaglobulinemia, and resistance to viral infections. The New England Journal of Medicine. 370: 1615-25. PMID 24716661 DOI: 10.1056/NEJMoa1302846  0.88
2014 Herman SE, Niemann CU, Farooqui M, Jones J, Mustafa RZ, Lipsky A, Saba N, Martyr S, Soto S, Valdez J, Gyamfi JA, Maric I, Calvo KR, Pedersen LB, Geisler CH, et al. Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia. 28: 2188-96. PMID 24699307 DOI: 10.1038/leu.2014.122  0.88
2014 Korde N, Carlsten M, Lee MJ, Minter A, Tan E, Kwok M, Manasanch E, Bhutani M, Tageja N, Roschewski M, Zingone A, Costello R, Mulquin M, Zuchlinski D, Maric I, ... Calvo KR, et al. A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma. Haematologica. 99: e81-3. PMID 24658821 DOI: 10.3324/haematol.2013.103085  0.88
2014 Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, ... ... Calvo KR, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. The New England Journal of Medicine. 370: 911-20. PMID 24552284 DOI: 10.1056/NEJMoa1307361  0.88
2014 McDermott DH, Liu Q, Velez D, Lopez L, Anaya-O'Brien S, Ulrick J, Kwatemaa N, Starling J, Fleisher TA, Priel DA, Merideth MA, Giuntoli RL, Evbuomwan MO, Littel P, Marquesen MM, ... ... Calvo KR, et al. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood. 123: 2308-16. PMID 24523241 DOI: 10.1182/blood-2013-09-527226  0.88
2014 Tembhare PR, Yuan CM, Venzon D, Braylan R, Korde N, Manasanch E, Zuchlinsky D, Calvo K, Kurlander R, Bhutani M, Tageja N, Maric I, Mulquin M, Roschewski M, Kwok M, et al. Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases Leukemia Research. 38: 371-376. PMID 24462038 DOI: 10.1016/j.leukres.2013.12.007  0.88
2014 Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 123: 1818-25. PMID 24345753 DOI: 10.1182/blood-2013-10-534743  0.88
2014 Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 123: 809-21. PMID 24227816 DOI: 10.1182/blood-2013-07-515528  0.88
2014 Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, ... Calvo KR, et al. Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia. 28: 413-6. PMID 24045500 DOI: 10.1038/leu.2013.268  0.88
2014 Manasanch EE, Braylan R, Stetler-Stevenson M, Yuan C, Gounden V, Korde N, Tageja N, Bhutani M, Calvo K, Maric I, Roschewski M, Staudt LM, Landgren O. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma Leukemia and Lymphoma. 55: 1402-1403. PMID 23915224 DOI: 10.3109/10428194.2013.831091  0.88
2013 Kreitman RJ, Wilson W, Calvo KR, Arons E, Roth L, Sapolsky J, Zhou H, Raffeld M, Stetler-Stevenson M. Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6873-81. PMID 24277451 DOI: 10.1158/1078-0432.CCR-13-1752  0.88
2013 Bat T, Steinberg SM, Childs R, Calvo KR, Barrett AJ, Battiwalla M, Baird K, Zhang D, Pulanic D, Dunbar CE, Pavletic SZ. Active thrombopoiesis is associated with worse severity and activity of chronic GVHD. Bone Marrow Transplantation. 48: 1569-73. PMID 23832091 DOI: 10.1038/bmt.2013.95  0.88
2013 Bauer TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 964-72. PMID 23531552 DOI: 10.1038/mt.2013.34  0.88
2013 Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC. Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Molecular & Cellular Proteomics : McP. 12: 1621-31. PMID 23449826 DOI: 10.1074/mcp.M112.026427  0.88
2013 Shao H, Calvo KR, Grönborg M, Tembhare PR, Kreitman RJ, Stetler-Stevenson M, Yuan CM. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leukemia Research. 37: 401-9. PMID 23347903 DOI: 10.1016/j.leukres.2012.11.021  0.88
2013 Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, et al. Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study. Leukemia & Lymphoma. 54: 2215-8. PMID 23311294 DOI: 10.3109/10428194.2013.764419  0.88
2013 Lee JM, Hays JL, Noonan AM, Squires J, Minasian L, Annunziata C, Wood BJ, Yu M, Calvo KR, Houston N, Azad N, Kohn EC. Feasibility and safety of sequential research-related tumor core biopsies in clinical trials. Cancer. 119: 1357-64. PMID 23280317 DOI: 10.1002/cncr.27916  0.88
2013 Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE. Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion. Transfusion. 53: 1201-4. PMID 23043309 DOI: 10.1111/j.1537-2995.2012.03918.x  0.88
2012 Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME, Liu Y, Lee Y, Calvo KR, Keles S, Zhang J, Holland SM, Bresnick EH. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. The Journal of Clinical Investigation. 122: 3692-704. PMID 22996659 DOI: 10.1172/JCI61623  0.88
2012 Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. The New England Journal of Medicine. 367: 11-9. PMID 22762314 DOI: 10.1056/NEJMoa1200931  0.88
2012 Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. American Journal of Hematology. 87: 916-22. PMID 22473867 DOI: 10.1002/ajh.23174  0.88
2012 Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 119: 3330-2. PMID 22210875 DOI: 10.1182/blood-2011-09-379339  0.88
2012 Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica. 97: 586-94. PMID 22102710 DOI: 10.3324/haematol.2011.048132  0.88
2012 Calvo KR, Hickstein DD, Holland SM. MonoMAC and GATA2 deficiency: Overlapping clinical and pathological features with aplastic anemia and idiopathic CD4 + lymphocytopenia Haematologica. 97: 12-13. DOI: 10.3324/haematol.2012.063396  0.88
2011 Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, Hsu AP, Zerbe CS, Calvo KR, Wilder J, Kurlander R, Olivier KN, Holland SM, Hickstein DD. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood. 118: 3715-20. PMID 21816832 DOI: 10.1182/blood-2011-06-365049  0.88
2011 Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 118: 2653-5. PMID 21670465 DOI: 10.1182/blood-2011-05-356352  0.88
2011 Calvo KR, Vinh DC, Maric I, Wang W, Noel P, Stetler-Stevenson M, Arthur DC, Raffeld M, Dutra A, Pak E, Myung K, Hsu AP, Hickstein DD, Pittaluga S, Holland SM. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica. 96: 1221-5. PMID 21508125 DOI: 10.3324/haematol.2011.041152  0.88
2011 Maric I, Calvo KR. Mastocytosis: the new differential diagnosis of CD30-positive neoplasms. Leukemia & Lymphoma. 52: 732-3. PMID 21463113 DOI: 10.3109/10428194.2011.561389  0.88
2011 Calvo KR, Landgren O, Roccaro AM, Ghobrial IM. Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma. Seminars in Hematology. 48: 39-45. PMID 21232657 DOI: 10.1053/j.seminhematol.2010.11.007  0.88
2011 Calvo KR, McCoy CS, Stetler-Stevenson M. Flow cytometry immunophenotyping of hematolymphoid neoplasia. Methods in Molecular Biology (Clifton, N.J.). 699: 295-316. PMID 21116989 DOI: 10.1007/978-1-61737-950-5_14  0.88
2010 Annunziata CM, Walker AJ, Minasian L, Yu M, Kotz H, Wood BJ, Calvo K, Choyke P, Kimm D, Steinberg SM, Kohn EC. Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2 Clinical Cancer Research. 16: 664-672. PMID 20068097 DOI: 10.1158/1078-0432.CCR-09-2308  0.88
2009 Pernas FG, Allen CT, Winters ME, Yan B, Friedman J, Dabir B, Saigal K, Mundinger GS, Xu X, Morris JC, Calvo KR, Van Waes C, Chen Z. Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2361-72. PMID 19318490 DOI: 10.1158/1078-0432.CCR-08-1011  0.88
2008 Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A, Shih JH, Jaffe ES. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood. 112: 3818-26. PMID 18682601 DOI: 10.1182/blood-2008-02-138933  0.88
2007 Kurup SK, Levy-Clarke G, Calvo KR, Jaffe ES, Nussenblatt RB, Chan CC. Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids. Clinical & Experimental Ophthalmology. 35: 468-72. PMID 17651253 DOI: 10.1111/j.1442-9071.2007.01517.x  0.88
2006 Ingkanisorn WP, Paterson DI, Calvo KR, Rosing DR, Schwartzentruber DJ, Fuisz AR, Arai AE. Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society For Cardiovascular Magnetic Resonance. 8: 353-60. PMID 16669178 DOI: 10.1080/10976640500452000  0.88
2006 Wang GG, Calvo KR, Pasillas MP, Sykes DB, Häcker H, Kamps MP. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nature Methods. 3: 287-93. PMID 16554834 DOI: 10.1038/nmeth865  0.88
2006 Mundinger GS, Espina V, Liotta LA, Petricoin EF, Calvo KR. Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray Targeted Oncology. 1: 151-167. DOI: 10.1007/s11523-006-0025-2  0.88
2005 Calvo KR, Liotta LA, Petricoin EF. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Bioscience Reports. 25: 107-25. PMID 16222423 DOI: 10.1007/s10540-005-2851-3  0.88
2004 Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Advances in Anatomic Pathology. 11: 227-38. PMID 15322489 DOI: 10.1097/01.pap.0000138144.11635.f8  0.88
2002 Calvo KR, Sykes DB, Pasillas MP, Kamps MP. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene. 21: 4247-56. PMID 12082612 DOI: 10.1038/sj.onc.1205516  0.88
2001 Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13120-5. PMID 11687616 DOI: 10.1073/pnas.231115398  0.88
2000 Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Molecular and Cellular Biology. 20: 3274-85. PMID 10757811 DOI: 10.1128/MCB.20.9.3274-3285.2000  0.88
1999 Calvo KR, Knoepfler P, McGrath S, Kamps MP. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene. 18: 8033-43. PMID 10637514 DOI: 10.1038/sj.onc.1203377  0.88
1997 Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proceedings of the National Academy of Sciences of the United States of America. 94: 14553-8. PMID 9405651 DOI: 10.1073/pnas.94.26.14553  0.88
1996 Calvo KR, Babior BM, Gottlieb RA. Transglutamination of a single major 43 kDa protein in the cytoskeleton of apoptotic cells from the human T lymphoblastoid line, Jurkat Journal of Investigative Medicine. 44: 109A.  0.88
Low-probability matches
2020 Obiorah IE, Francischetti IMB, Wang HW, Ahn IE, Wang W, Raffeld M, Kreitman RJ, Wiestner A, Calvo KR. Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features. Leukemia & Lymphoma. 1-11. PMID 32755330 DOI: 10.1080/10428194.2020.1797007  0.04
2020 Chihara D, Arons E, Stetler-Stevenson M, Yuan CM, Wang HW, Zhou H, Raffeld M, Xi L, Steinberg SM, Feurtado J, James L, Wilson W, Braylan RC, Calvo KR, Maric I, et al. Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902250. PMID 32109194 DOI: 10.1200/JCO.19.02250  0.04
2019 Espinoza DA, Fan X, Yang D, Cordes SF, Truitt LL, Calvo KR, Yabe IM, Demirci S, Hope KJ, Hong SG, Krouse A, Metzger M, Bonifacino A, Lu R, Uchida N, et al. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31023523 DOI: 10.1016/j.ymthe.2019.04.003  0.04
2019 Dulau-Florea A, Maric I, Calvo KR, Braylan RC. Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates. Seminars in Hematology. 56: 65-68. PMID 30573047 DOI: 10.1053/j.seminhematol.2018.05.011  0.04
2019 Calvo KR, Braylan RC. Advances in diagnostic hematopathology. Seminars in Hematology. 56: 1. PMID 30573038 DOI: 10.1053/j.seminhematol.2018.07.002  0.04
2018 Dulau-Florea AE, Young NS, Maric I, Calvo KR, Dunbar CE, Townsley DM, Winkler T, Monreal M, Jiang C, Jordan EK, Braylan RC. Bone Marrow as a Source of Cells for Paroxysmal Nocturnal Hemoglobinuria Detection. American Journal of Clinical Pathology. PMID 29982419 DOI: 10.1093/ajcp/aqy053  0.04
2018 Boutboul D, Kuehn HS, Van de Wyngaert Z, Niemela JE, Callebaut I, Stoddard J, Lenoir C, Barlogis V, Farnarier C, Vely F, Yoshida N, Kojima S, Kanegane H, Hoshino A, Hauck F, ... ... Calvo KR, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. The Journal of Clinical Investigation. PMID 29889099 DOI: 10.1172/JCI98164  0.04
2016 Dulau Florea AE, Braylan RC, Schafernak KT, Williams KW, Daub J, Goyal RK, Puck JM, Rao VK, Pittaluga S, Holland SM, Uzel G, Calvo KR. Abnormal B-Cell Maturation in the Bone Marrow of Patients with Germline Mutations in PIK3CD. The Journal of Allergy and Clinical Immunology. PMID 27697496 DOI: 10.1016/j.jaci.2016.08.028  0.04
2016 Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, ... ... Calvo KR, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Jci Insight. 1. PMID 27588307 DOI: 10.1172/jci.insight.88782  0.04
2015 Saleh LM, Wang W, Herman SEM, Farooqui M, Sun C, Barber E, Corrigan-Cummins M, Saba N, Awad H, Wiestner A, Calvo KR. Ibrutinib Responsive Micro-RNAs and Upregulation of Tumor Suppressor Targets in Chronic Lymphocytic Leukemia Blood. 126: 487-487. DOI: 10.1182/blood.V126.23.487.487  0.04
2020 Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, Balanda N, Ross DL, Ospina Cardona D, Wu Z, Patel B, Manthiram K, Groarke EM, Gutierrez-Rodrigues F, Hoffmann P, ... ... Calvo KR, et al. Somatic Mutations in and Severe Adult-Onset Autoinflammatory Disease. The New England Journal of Medicine. PMID 33108101 DOI: 10.1056/NEJMoa2026834  0.01
2020 Johnson KD, Conn DJ, Shishkova E, Katsumura KR, Liu P, Shen S, Ranheim EA, Kraus SG, Wang W, Calvo KR, Hsu AP, Holland SM, Coon JJ, Keles S, Bresnick EH. Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories. The Journal of Experimental Medicine. 217. PMID 32736380 DOI: 10.1084/jem.20191526  0.01
2020 Wu Z, Gao S, Diamond C, Kajigaya S, Chen J, Shi R, Palmer C, Hsu AP, Calvo KR, Hickstein DD, Holland SM, Young NS. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency. Blood Advances. 4: 2656-2670. PMID 32556286 DOI: 10.1182/bloodadvances.2019001352  0.01
2020 Vicente A, Patel BA, Gutierrez-Rodrigues F, Groarke E, Giudice V, Lotter J, Feng X, Kajigaya S, Weinstein B, Barranta E, Olnes MJ, Parikh AR, Albitar M, Wu CO, Shalhoub R, ... Calvo KR, et al. Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome. Haematologica. PMID 32439728 DOI: 10.3324/haematol.2020.249995  0.01
2020 Fan X, Desmond R, Winkler T, Young DJ, Dumitriu B, Townsley DM, Gutierrez-Rodrigues F, Lotter J, Valdez J, Sellers SE, Barranta ME, Shalhoub RN, Wu CO, Albitar M, Calvo KR, et al. Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Advances. 4: 1700-1710. PMID 32330244 DOI: 10.1182/bloodadvances.2020001657  0.01
2020 Wang W, Shim YK, Michalek JE, Barber E, Saleh LM, Choi BY, Wang CP, Ketchum N, Costello R, Marti GE, Vogt RF, Landgren O, Calvo KR. Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance. Journal of Toxicology and Environmental Health. Part A. 1-10. PMID 32285757 DOI: 10.1080/15287394.2020.1749919  0.01
2019 de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, Calvo KR, Marrero B, Moir S, Oler AJ, Deng Z, Montealegre Sanchez GA, Ahmed A, Allenspach E, Arabshahi B, et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. The Journal of Clinical Investigation. PMID 31874111 DOI: 10.1172/JCI129301  0.01
2019 Bradley CP, Chen C, Oetjen KA, Yan C, Panjwani R, Hauffe S, Calvo KR, Yuan C, Patel PA, Montgomery ND, Foster MC, Battiwalla M, Barrett AJ, Gibbons RJ, Ito S. Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier. Blood Advances. 3: 2627-2631. PMID 31501157 DOI: 10.1182/bloodadvances.2019000013  0.01
2019 Oetjen KA, Levoska MA, Tamura D, Ito S, Douglas D, Khan SG, Calvo KR, Kraemer KH, DiGiovanna JJ. Predisposition to hematologic malignancies in patients with xeroderma pigmentosum. Haematologica. PMID 31439674 DOI: 10.3324/haematol.2019.223370  0.01
2019 Droll SH, Hsu YS, Drake SK, Kim A, Wang W, Calvo KR, Cao Z, Hu TY, Zhao Z. Differential Processing of High-Molecular-Weight Kininogen during Normal Pregnancy. Rapid Communications in Mass Spectrometry : Rcm. PMID 31412146 DOI: 10.1002/rcm.8552  0.01
2019 Weinberg OK, Kuo F, Calvo KR. Germline Predisposition to Hematolymphoid Neoplasia. American Journal of Clinical Pathology. PMID 31309983 DOI: 10.1093/ajcp/aqz067  0.01
2019 McReynolds LJ, Zhang Y, Yang Y, Tang J, Mulé M, Hsu AP, Townsley DM, West RR, Zhu J, Hickstein DD, Holland SM, Calvo KR, Hourigan CS. Rapid progression to AML in a patient with germline mutation and acquired Q61K mutation. Leukemia Research Reports. 12: 100176. PMID 31245276 DOI: 10.1016/j.lrr.2019.100176  0.01
2019 Galera P, Dulau-Florea A, Calvo KR. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia. International Journal of Laboratory Hematology. 41: 131-141. PMID 31069978 DOI: 10.1111/ijlh.12999  0.01
2019 Winkler T, Fan X, Cooper J, Desmond R, Young DJ, Townsley DM, Scheinberg P, Grasmeder S, Larochelle A, Desierto M, Valdez J, Lotter J, Wu C, Shalhoub RN, Calvo KR, et al. Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution. Blood. PMID 30992268 DOI: 10.1182/blood.2019000478  0.01
2019 Francischetti IMB, Calvo KR. Hairy cell leukemia coexistent with chronic lymphocytic leukemia. Blood. 133: 1264. PMID 30872271 DOI: 10.1182/blood-2018-12-885145  0.01
2019 McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, et al. Plerixafor for the Treatment of WHIM Syndrome. The New England Journal of Medicine. 380: 163-170. PMID 30625055 DOI: 10.1056/NEJMoa1808575  0.01
2019 McReynolds LJ, Yang Y, Yuen Wong H, Tang J, Zhang Y, Mulé MP, Daub J, Palmer C, Foruraghi L, Liu Q, Zhu J, Wang W, West RR, Yohe ME, Hsu AP, ... ... Calvo KR, et al. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations. Leukemia Research. 76: 70-75. PMID 30578959 DOI: 10.1016/j.leukres.2018.11.013  0.01
2019 Kallen ME, Dulau-Florea A, Wang W, Calvo KR. Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications. Seminars in Hematology. 56: 69-82. PMID 30573048 DOI: 10.1053/j.seminhematol.2018.05.016  0.01
2019 Hodes A, Calvo KR, Dulau A, Maric I, Sun J, Braylan R. The challenging task of enumerating blasts in the bone marrow. Seminars in Hematology. 56: 58-64. PMID 30573046 DOI: 10.1053/j.seminhematol.2018.07.001  0.01
2019 Chihara D, Arons E, Stetler-Stevenson M, Yuan C, Zhou H, Raffeld M, Xi L, Steinberg SM, Wisch L, Feurtado J, James-Echenique L, Braylan R, Calvo KR, Maric I, Dulau A, et al. Randomized phase II study of cladribine with simultaneous or delayed rituximab in patients with untreated hairy cell leukemia. Journal of Clinical Oncology. 37: 7003-7003. DOI: 10.1200/JCO.2019.37.15_SUPPL.7003  0.01
2019 Soukup A, Johnson KD, Conn DJ, Shishkova E, Katsumura KR, Liu P, Ranheim EA, Calvo KR, Hsu AP, Holland SM, Coon JJ, Keles S, Bresnick EH. GATA2-Dependent Developmental and Regenerative Networks Blood. 134: 1182-1182. DOI: 10.1182/blood-2019-126875  0.01
2019 Wu Z, Gao S, Kajigaya S, Chen J, Shi R, Diamond C, Palmer C, Hsu AP, Calvo KR, Hickstein DD, Holland SM, Young NS. Single-Cell RNA Sequencing Reveals a Distinct Transcriptome Signature of Hematopoiesis in GATA2 Deficiency Blood. 134: 3735-3735. DOI: 10.1182/blood-2019-124774  0.01
2019 Chihara D, Arons E, Stetler-Stevenson M, Yuan CM, Wang H, Zhou H, Raffeld M, Xi L, Steinberg SM, Feurtado J, James-Echenique L, Wilson W, Braylan RC, Calvo KR, Maric I, et al. Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia Variant Blood. 134: 1536-1536. DOI: 10.1182/blood-2019-124515  0.01
2019 Khan S, Oetjen K, Lee M, Yang H, Levoska M, Tamura D, Ito S, Calvo K, Douglas D, DiGiovanna J, Kraemer K. 127 Digital droplet PCR assays for the detection of leukemia mutations in a xeroderma pigmentosum patient with mixed phenotype acute leukemia Journal of Investigative Dermatology. 139: S22. DOI: 10.1016/J.JID.2019.03.203  0.01
2018 Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE, Ravandi F, Jabbour EJ, Al-Hamal Z, Konopleva M, Ning J, Xiao L, Hidalgo Lopez J, Kornblau SM, Andreeff M, ... ... Calvo KR, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. PMID 30500073 DOI: 10.1002/cncr.31896  0.01
2018 Galera P, Hsu AP, Wang W, Droll S, Chen R, Schwartz JR, Klco JM, Arai S, Maese L, Zerbe C, Parta MJ, Young NS, Holland SM, Hickstein DD, Calvo KR. Donor-derived MDS/AML in families with germline GATA2 mutation. Blood. PMID 30232126 DOI: 10.1182/blood-2018-07-861070  0.01
2018 McReynolds LJ, Calvo KR, Holland SM. Germline GATA2 Mutation and Bone Marrow Failure. Hematology/Oncology Clinics of North America. 32: 713-728. PMID 30047422 DOI: 10.1016/j.hoc.2018.04.004  0.01
2018 Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, ... ... Calvo KR, et al. Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. Cell. 173: 1439-1453.e19. PMID 29856956 DOI: 10.1016/j.cell.2018.05.013  0.01
2018 Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, Jesus AA, ... ... Calvo KR, et al. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. The Journal of Clinical Investigation. PMID 29649002 DOI: 10.1172/JCI98814  0.01
2018 Ahn IE, Farooqui MZH, Tian X, Valdez J, Sun C, Soto S, Lotter J, Housel S, Stetler-Stevenson M, Yuan CM, Maric I, Calvo KR, Nierman P, Hughes TE, Saba NS, et al. Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase II study. Blood. PMID 29483101 DOI: 10.1182/blood-2017-12-820910  0.01
2018 Parta M, Shah NN, Baird K, Rafei H, Calvo KR, Hughes T, Cole K, Kenyon M, Blacklock Schuver B, Cuellar-Rodriguez J, Zerbe CS, Holland SM, Hickstein DD. Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29412158 DOI: 10.1016/j.bbmt.2018.01.030  0.01
2018 Giannelou A, Wang H, Zhou Q, Park YH, Abu-Asab MS, Ylaya K, Stone DL, Sediva A, Sleiman R, Sramkova L, Bhatla D, Serti E, Tsai WL, Yang D, Bishop K, ... ... Calvo KR, et al. Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors. Annals of the Rheumatic Diseases. PMID 29358286 DOI: 10.1136/annrheumdis-2017-212401  0.01
2018 Vicente A, Gutierrez-Rodrigues F, Giudice V, Wu Z, Kajigaya S, Fernandez Ibanez MdP, Albitar M, Weinstein B, Calvo KR, Townsley DM, Scheinberg P, Dunbar CE, Young NS, Winkler T. Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS) Blood. 132: 229-229. DOI: 10.1182/blood-2018-99-119780  0.01
2018 Scheiermann J, West R, Embree LJ, Calvo KR, Shah NN, Tuschong L, Parta M, Hickstein DD. Prognostic Value of IPSS-R Score, Cytogenetic Aberrations, and Cytopenias on Outcome of Allogeneic Hematopoietic Stem Cell Transplant in Myelodysplastic Syndrome in GATA2 Deficiency Blood. 132: 3094-3094. DOI: 10.1182/blood-2018-99-114874  0.01
2018 Wang W, Shim YK, Michalek JE, Barber E, Saleh LM, Choi BY, Wang C, Ketchum N, Costello R, Marti GE, Vogt R, Landgren O, Calvo KR. Measurement of Serum microRNAs in US Veterans with Monoclonal Gammopathy of Undetermined Significance Blood. 132: 5576-5576. DOI: 10.1182/blood-2018-99-114821  0.01
2018 Fan X, Winkler T, Desmond R, Dumitriu B, Townsley DM, Fernandez Ibanez MdP, Gutierrez-Rodrigues F, Grasmeder S, Barranta ME, Madey D, Lotter J, Valdez J, Calvo KR, Wu C, Young NS, et al. Eltrombopag for Moderate Aplastic Anemia and Unilineage Cytopenias: Dosing, Long-Term Follow-up, Clonal Evolution and Somatic Mutation Profiling Blood. 132: 538-538. DOI: 10.1182/blood-2018-99-112994  0.01
2018 Kazandjian D, Korde N, Mailankody S, Zhang Y, Hsu J, Hill E, Morrison C, Divakarla S, Kwok ML, Manasanch EE, Bhutani M, Tageja N, Galera P, Dulau-Florea A, Salem D, ... ... Calvo KR, et al. A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term Deep Remissions and Prolonged Progression-Free Duration Regardless of Age or Cytogenetic Risk after 5 Years of Follow up Blood. 132: 1957-1957. DOI: 10.1182/blood-2018-99-111712  0.01
2018 Levoska M, Tamura D, Ito S, Calvo K, Douglas D, Oetjen K, Khan S, Kraemer K, DiGiovanna J. 137 Mixed phenotype acute leukemia in xeroderma pigmentosum Journal of Investigative Dermatology. 138: S23. DOI: 10.1016/j.jid.2018.03.142  0.01
2017 Bogaert DJ, Kuehn HS, Bonroy C, Calvo KR, Dehoorne J, Vanlander AV, De Bruyne M, Cytlak U, Bigley V, De Baets F, De Baere E, Rosenzweig SD, Haerynck F, Dullaers M. A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B cell maturation defects. The Journal of Allergy and Clinical Immunology. PMID 28927821 DOI: 10.1016/j.jaci.2017.08.019  0.01
2017 Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M. Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma. Leukemia & Lymphoma. 1-9. PMID 28540748 DOI: 10.1080/10428194.2017.1321746  0.01
2017 Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, ... Calvo KR, et al. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. The New England Journal of Medicine. 376: 1540-1550. PMID 28423296 DOI: 10.1056/NEJMoa1613878  0.01
2017 Schlums H, Jung M, Han H, Theorell J, Bigley V, Chiang SC, Allan DS, Davidson-Moncada JK, Dickinson RE, Holmes TD, Hsu AP, Townsley D, Winkler T, Wang W, Aukrust P, ... ... Calvo KR, et al. Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells. Blood. PMID 28209719 DOI: 10.1182/blood-2016-08-734236  0.01
2016 Saleh LM, Wang W, Herman SE, Saba NS, Anastas V, Barber E, Corrigan-Cummins M, Farooqui M, Sun C, Sarasua SM, Zhao Z, Abousamra NK, Elbaz O, Abdelghaffar HA, Wiestner A, ... Calvo KR, et al. Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia. Leukemia. PMID 27431016 DOI: 10.1038/leu.2016.181  0.01
2016 Kazandjian D, Korde NS, Roschewski M, Mailankody S, Morrison C, Manasanch EE, Kwok ML, Tageja N, Bhutani M, Zingone A, Costello R, Zhang Y, Mulquin M, Lamping L, Carpenter A, ... ... Calvo KR, et al. Sustained Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (DEX) Followed By 2 Years of Lenalidomide Maintenance (CRd-R): Updated Results of a Phase 2 Study Blood. 128: 4527-4527. DOI: 10.1182/blood.V128.22.4527.4527  0.01
2016 Anastas V, Wang W, Price S, Zhao Z, Rao VK, Calvo KR. Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations Blood. 128: 4268-4268. DOI: 10.1182/blood.V128.22.4268.4268  0.01
2016 Goswami M, Oetjen K, Mulé MP, Sheela S, Wong HY, Liu Q, Calvo KR, Lai CE, Hourigan CS. Increased Frequencies of PD-1+ CD8+ Marrow-Infiltrating Lymphocytes Associated with Highly Clonal T-Lymphocyte Expansions in Relapsed and Refractory AML Patients but Not Healthy Adults Blood. 128: 1644-1644. DOI: 10.1182/blood.V128.22.1644.1644  0.01
2015 Townsley DM, Dumitriu B, Scheinberg P, Desmond R, Feng X, Rios O, Weinstein B, Valdez J, Winkler T, Desierto M, Leuva H, Wu C, Calvo KR, Larochelle A, Dunbar CE, et al. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia Accelerates Count Recovery and Increases Response Rates Blood. 126: LBA-2-LBA-2. DOI: 10.1182/blood.V126.23.LBA-2.LBA-2  0.01
2015 Yang Y, Zhang Y, Zhu J, Lai CE, Tang J, McReynolds LJ, Hsu AP, Hickstein DD, Townsley DM, Holland SM, Calvo KR, Hourigan CS. Development of Somatic NRAS Mutation Associated with Rapid Transition from Germline GATA2 Mutation Associated Myelodysplastic Syndrome to Acute Myeloid Leukemia Blood. 126: 3616-3616. DOI: 10.1182/blood.V126.23.3616.3616  0.01
2015 Hickstein DD, Shah NN, Freeman AF, Zerbe C, Holland SM, Parta M. Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency Blood. 126: 1214-1214. DOI: 10.1182/blood.v126.23.1214.1214  0.01
2015 Giannelou AA, Zhou Q, Stoffels M, Ombrello A, Stone D, Edwan J, Pelletier M, Tsai W, Calvo K, Rosenzweig S, Barron K, Gadina M, Aksentijevich I, Daniel L, Kastner D. A2.35 TRNT1missense mutations define a new periodic fever syndrome Annals of the Rheumatic Diseases. 74: A30.1-A30. DOI: 10.1136/annrheumdis-2015-207259.70  0.01
2015 Florea AD, Townsley D, Hsu A, Ganapathi K, Barber E, Hickstein D, Braylan R, Young N, Holland S, Calvo K. 288 GATA2-ASSOCIATED MYELODYSPLASTIC SYNDROME(MDS) HAS UNIQUE IMMUNOPHENOTYPIC FEATURES THAT DIFFER FROM DE NOVO MDS Leukemia Research. 39: S143-S144. DOI: 10.1016/S0145-2126(15)30289-7  0.01
2015 Hsu A, Townsley D, DeSierto M, Hickstein D, Calvo K, Holland S, Young N. 46 HIGH FREQUENCY OF GATA2 MUTATIONS IN APLASTIC ANEMIA AND HYPOCELLULAR MYELODYSPLASTIC SYNDROME Leukemia Research. 39: S21. DOI: 10.1016/S0145-2126(15)30047-3  0.01
2015 Bryke CR, McDermott DH, Gao J, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Hsu N, Dai Z, Marquesen MM, Stregevsky E, Kwatemaa N, Theobald N, ... ... Calvo KR, et al. WHIM Syndrome Cured by Chromothripsis Cancer Genetics. 208: 358-359. DOI: 10.1016/j.cancergen.2015.05.007  0.01
2014 Calvo KR, Daar ES. Antiretroviral therapy: treatment-experienced individuals. Infectious Disease Clinics of North America. 28: 439-56. PMID 25151565 DOI: 10.1016/j.idc.2014.06.005  0.01
2014 Ghafoor A, Calvo KR, Corrigan-Cummins M, Simakova O, Costello R, Yuan C, Stetler-Stevenson M, Korde N, Roschewski MJ, Landgren O, Maric I. Immunophenotypic profiles of plasma cells and tumor burden in patients with smoldering myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS). Journal of Clinical Oncology. 32: e19589-e19589. DOI: 10.1200/jco.2014.32.15_suppl.e19589  0.01
2014 Bhutani M, Turkbey B, Tan E, Korde N, Kwok M, Manasanch EE, Tageja N, Mailankody S, Roschewski MJ, Mulquin M, Lamping E, Weiss BM, Mena E, Lindenberg L, Calvo KR, et al. Focal bone marrow processes and early bone lesions in patients with multiple myeloma (MM) precursor diseases: A prospective study using molecular imaging. Journal of Clinical Oncology. 32: 8587-8587. DOI: 10.1200/jco.2014.32.15_suppl.8587  0.01
2014 Goswami M, McGowan KS, Lu K, Jain NA, Candia J, Hensel NF, Tang J, Calvo KR, Battiwalla M, Barrett AJ, Hourigan CS. A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation Blood. 124: 667-667. DOI: 10.1182/blood.v124.21.667.667  0.01
2014 Spinner MA, Odio C, Calvo KR, Hsu AP, Zerbe CS, Cuellar-Rodriguez J, Ker JP, Stoudenmire CJ, Fadare O, Ghosh A, Mace EM, Orange JS, Hickstein DD, Holland SM. Hemophagocytic Lymphohistiocytosis Associated with NK Cell Dysfunction and Disseminated Herpesvirus Infection in GATA2 Deficiency/Monomac Syndrome Blood. 124: 4978-4978. DOI: 10.1182/blood.V124.21.4978.4978  0.01
2014 Landgren O, Roschewski M, Mailankody S, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Zingone A, Costello R, Burton D, Zhang Y, Wu P, Carter G, Mulquin M, ... ... Calvo KR, et al. Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Final Results from the NCI Phase 2 Pilot Study Blood. 124: 4746-4746. DOI: 10.1182/blood.V124.21.4746.4746  0.01
2014 Dulau Florea AE, Braylan RC, Schafernak KT, Pittaluga S, Holland SM, Uzel G, Calvo KR. Abnormal B-Cell Maturation Pattern in the Bone Marrow of Patients with Germline Mutations in PIK3CD Blood. 124: 2752-2752. DOI: 10.1182/blood.V124.21.2752.2752  0.01
2014 Korde N, Mailankody S, Roschewski M, Faham M, Kotwaliwale C, Moorhead M, Kwok ML, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Costello R, Zhang Y, Zingone A, Burton D, ... ... Calvo KR, et al. Minimal Residual Disease (MRD) Testing in Newly Diagnosed Multiple myeloma (MM) Patients: A Prospective Head-to-Head Assessment of Cell-Based, Molecular, and Molecular-Imaging Modalities Blood. 124: 2105-2105. DOI: 10.1182/blood.V124.21.2105.2105  0.01
2014 Sokolic RA, Chonat S, Risinger M, Eckhaus M, Garabedian E, Calvo KR, Maric I, Kalfa TA, Candotti F. Cation Leak in Red Blood Cells of Patients with Wiskott-Aldrich Syndrome Leads to Non-Immunologic Hemolysis Blood. 124: 1338-1338. DOI: 10.1182/blood.V124.21.1338.1338  0.01
2014 Cuellar-Rodriguez J, Hickstein DD, Grossman JK, Parta M, Gea-Banacloche J, Zerbe CS, Freeman AF, Holland SM, Calvo KR. Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency Blood. 124: 1247-1247. DOI: 10.1182/blood.V124.21.1247.1247  0.01
2013 Manasanch EE, Korde N, Yuan C, Kwok M, Tageja N, Bhutani M, Flanders AW, Zingone A, Costello R, Tembhare P, Mulquin M, Zuchlinski D, Maric I, Calvo KR, Steinberg SM, et al. Biologic variations of plasma cells in the bone marrow of smoldering multiple myeloma (SMM) and multiple myeloma (MM) patients: Multiple biopsies in the same patient. Journal of Clinical Oncology. 31: e19506-e19506. DOI: 10.1200/jco.2013.31.15_suppl.e19506  0.01
2013 Tageja N, Wang W, Plyler R, Corrigan-Cummins M, Korde N, Manasanch EE, Bhutani M, Kwok M, Flanders AW, Zuchlinski D, Mulquin M, Costello R, Roschewski MJ, Landgren O, Calvo KR, et al. Altered cytokine profiles in multiple myeloma (MM) and precursor disease: Predictors of progression and potential targets for treatment. Journal of Clinical Oncology. 31: 8597-8597. DOI: 10.1200/jco.2013.31.15_suppl.8597  0.01
2013 Bhutani M, Costello R, Korde N, Manasanch EE, Kwok M, Tageja N, Mailankody S, Kazandjian D, Wu P, Zingone A, Burton D, Carter G, Zuchlinski D, Mulquin M, Maric I, ... Calvo KR, et al. Serum Heavy-Light Chains (HLC) and Free Light Chains (FLC) As Predictors For Early CR In Newly Diagnosed Myeloma Patients Treated With Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Blood. 122: 762-762. DOI: 10.1182/blood.v122.21.762.762  0.01
2013 Korde N, Zingone A, Kwok ML, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Costello R, Zhang Y, Burton D, Carter G, Wu P, Mulquin M, Zuchlinski D, ... ... Calvo KR, et al. Phase II Clinical and Correlative Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRD-R) Induces High Rates Of MRD Negativity In Newly Diagnosed Multiple Myeloma (MM) Patients Blood. 122: 538-538. DOI: 10.1182/blood.V122.21.538.538  0.01
2013 Larrea CFd, Zingone A, Manasanch EE, Korde N, Wu P, Costello R, Zuchlinski D, Mulquin M, Burton D, Maric I, Calvo KR, Stetler-Stevenson M, Yuan C, Roschewski M, Landgren O. Plasma Circulating Proteasomes As Biomarkers Along Natural History Of Asymptomatic Monoclonal Gammopathies Blood. 122: 3133-3133. DOI: 10.1182/blood.v122.21.3133.3133  0.01
2013 Cuellar-Rodriguez J, Freeman AF, Gea-Banacloche J, Su H, Grossman JK, Fry TJ, Holland SM, Hickstein DD. Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency Blood. 122: 2114-2114. DOI: 10.1182/blood.v122.21.2114.2114  0.01
2013 Landgren O, Mailankody S, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Zingone A, Costello R, Burton D, Zhang Y, Wu P, Carter G, Mulquin M, Zuchlinski D, ... ... Calvo KR, et al. Clinical and Correlative Pilot Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRd – R) In High Risk Smoldering Multiple Myeloma Patients Blood. 122: 1939-1939. DOI: 10.1182/blood.V122.21.1939.1939  0.01
2013 Mailankody S, Korde N, Faham M, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Weng L, Moorhead M, Costello R, Zhang Y, Zingone A, Burton D, Wu P, ... ... Calvo KR, et al. Minimal Residual Disease (MRD) Detection By Deep Sequencing In Newly Diagnosed Multiple Myeloma Patients Treated With Carfilzomib, Lenalidomide and Dexamethasone Blood. 122: 1902-1902. DOI: 10.1182/blood.v122.21.1902.1902  0.01
2013 Manasanch EE, de Larrea CF, Zingone A, Korde N, Tageja N, Bhutani M, Kazandjian D, Wu P, Costello R, Burton D, Carter G, Zuchlinski D, Mulquin M, Maric I, Calvo KR, et al. Enzymatic Activities Of Circulating Plasma Proteasomes (cProt) In Newly Diagnosed Multiple Myeloma (NDMM) Patients Undergoing Treatment With Carfilzomib, Lenalidomide and Dexamethasone (CRd) Blood. 122: 1877-1877. DOI: 10.1182/blood.v122.21.1877.1877  0.01
2013 Kurlander R, LI Y, Stetler-Stevenson M, Yuan C, Korde N, Mailankody S, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Costello R, Zhang Y, Zingone A, Wu P, ... ... Calvo KR, et al. Evaluation Of Circulating Cell-Free VDJ DNA As a Marker For Monitoring Patients With Multiple Myeloma (MM) During Treatment With Carfilzomib, Lenalidomide and Dexamethasone, Blood. 122: 1868-1868. DOI: 10.1182/blood.V122.21.1868.1868  0.01
2012 Kwok M, Korde N, Manasanch EE, Bhutani M, Maric I, Calvo KR, Zingone A, Costello R, Cherry BM, Yancey MA, Mulquin M, Roschewski MJ, Landgren O. Role of immune-related conditions in smoldering myeloma and MGUS. Journal of Clinical Oncology. 30: 8104-8104. DOI: 10.1200/jco.2012.30.15_suppl.8104  0.01
2012 Korde N, Zingone A, Kwok M, Manasanch EE, Costello R, Zuchlinski D, Mulquin M, Maric I, Calvo KR, Braylan RC, Yuan C, Tembhare PR, Stetler-Stevenson M, Arthur DC, Raffeld M, et al. Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients Blood. 120: 732-732. DOI: 10.1182/blood.V120.21.732.732  0.01
2012 Manier S, Sacco A, Maiso P, Zhang Y, Liu Y, Aljawai Y, Wang W, Corrigan-Cummins M, Leleu X, Calvo KR, Landgren O, Roccaro AM, Ghobrial I. Let-7 Microrna Family Members Regulate Cell Proliferation in Multiple Myeloma Blood. 120: 570-570. DOI: 10.1182/blood.V120.21.570.570  0.01
2012 Tembhare PR, Yuan C, Korde N, Manasanch EE, Kwok M, Roschewski M, Maric I, Calvo KR, Mulquin M, Zuchlinski D, Landgren O, Stetler-Stevenson M. Peripheral Blood Involvement with Minimal Disease Is Common in Multiple Myeloma but Not in Smoldering Myeloma Blood. 120: 4994-4994. DOI: 10.1182/blood.v120.21.4994.4994  0.01
2012 West RR, Hsu A, Calvo KR, Cuellar-Rodriguez J, Holland SM, Hickstein DD. ASXL1 mutations in GATA2-Deficiency Correlate with Leukemic Transformation Blood. 120: 405-405. DOI: 10.1182/blood.v120.21.405.405  0.01
2012 Kwok ML, Korde N, Manasanch EE, Flanders AW, Maric I, Calvo KR, Zingone A, Costello R, Cordaro D, Sato A, Mulquin M, Zuchlinski D, Roschewski M, Landgren O. Altered Plasma Cell Characteristics in Smoldering Myeloma and MGUS Patients with Preceding Immune-Related Conditions Blood. 120: 4006-4006. DOI: 10.1182/blood.v120.21.4006.4006  0.01
2012 Wang W, Corrigan-Cummins M, Vinh DC, Hsu AP, Hickstein DD, Holland SM, Calvo KR. MCL-1 and Mir-181c in GATA2 Mutation Associated Monomac and Familial Myelodysplastic Syndrome Blood. 120: 3807-3807. DOI: 10.1182/blood.v120.21.3807.3807  0.01
2012 Korde N, Liu QY, Kwok M, Manasanch EE, Simakova O, Mailankody S, Roschewski M, Zingone A, Costello R, Zuchlinski D, Mulquin M, Calvo KR, Braylan RC, Maric I, Landgren O. Early Myelodysplastic Changes Present in Substantial Proportion of Monoclonal Gammopathy of Unknown Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Patients Blood. 120: 1805-1805. DOI: 10.1182/blood.v120.21.1805.1805  0.01
2012 Alter BP, Giri N, Calvo KR, Maric I, Arthur DC, Hickstein DD, Hastings CA, Lee MA, Hsu A, Holland SM. Clinically Silent Carriers in Families with Myelodysplastic Syndrome Due to GATA2 Mutations Blood. 120: 1264-1264. DOI: 10.1182/blood.v120.21.1264.1264  0.01
2012 Johnson KD, Gao X, Sanalkumar R, Hsu AP, Ryu M, Wang J, Boyer ME, Liu Y, Calvo KR, Keles S, Zhang J, Holland SM, Bresnick EH. Genetic Determinants of the Definitive Hematopoietic Stem/Progenitor Cell Compartment Blood. 120: 1226-1226. DOI: 10.1182/blood.v120.21.1226.1226  0.01
2012 Rao VK, Oliveira JB, Niemela J, Davis J, Price S, Kuehn H, Calvo KR, Pittaluga S, Werner EJ, Lee J, Barbour M, Natter M, Loh ML, Fleisher TA. Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML) Blood. 120: 1033-1033. DOI: 10.1182/blood.V120.21.1033.1033  0.01
2011 Olnes MJ, Scheinberg P, Calvo K, Tang Y, Soto S, Feng X, Desmond RG, Lozier JN, Young NS, Dunbar CE. Eltrombopag Can Stimulate Trilineage Hematopoiesis with Transfusion Independence in Patients with Refractory Severe Aplastic Anemia: Results From a Phase II Trial Blood. 118: 54-54. DOI: 10.1182/blood.V118.21.54.54  0.01
2011 Costello R, Espana K, Korde N, Kwok M, Zingone A, Yancey MA, Mulquin M, Maric I, Calvo K, Tembhare PR, Yuan C, Stetler-Stevenson M, Landgren O. Hevylite™ Assays Detect a Hidden Immunoparesis Associated with Adverse Biology in Myeloma Precursor Disease: A Prospective Clinical Study Blood. 118: 5065-5065. DOI: 10.1182/blood.v118.21.5065.5065  0.01
2011 Zingone A, Korde N, Chen J, Xi L, Raffeld M, Holkova B, Kmieciak M, Sullivan D, Doyle A, Maric I, Calvo K, Yancey MA, Mulquin M, Annunziata C, Grant S, et al. Molecular Characterization and Clinical Correlations of MEK1/2 Inhibition (AZD6244) in Relapse or Refractory Multiple Myeloma: Analysis From a Phase II Study Blood. 118: 306-306. DOI: 10.1182/blood.v118.21.306.306  0.01
2011 Korde N, Trepel J, Carlsten M, Zingone A, Costello R, Yancey MA, Mulquin M, Maric I, Calvo K, Tembhare PR, Yuan C, Stetler-Stevenson M, Lee M, Alarcon S, Carter G, et al. A Phase II Trial of IPH2101 (anti-KIR mAb) in Smoldering Multiple Myeloma Blood. 118: 2944-2944. DOI: 10.1182/blood.v118.21.2944.2944  0.01
2011 Tembhare PR, Yuan C, Korde N, Maric I, Calvo K, Yancey MA, Mulquin M, Landgren O, Stetler-Stevenson M. CD81: A Novel, Specific and Highly Sensitive Marker in Flow Cytometric Diagnosis of Plasma Cell Dyscrasia Blood. 118: 2880-2880. DOI: 10.1182/blood.V118.21.2880.2880  0.01
2007 Calvo KR, Dabir B, Bandle R, Bond A, Jaffe ES. IL-4 Expression and Constitutive Activation of Erk Signaling In Vivo in Follicular Lymphoma. Blood. 110: 687-687. DOI: 10.1182/blood.v110.11.687.687  0.01
2006 Barnett CF, Tran K, Calvo KR, Machado RF. A CASE OF PULMONARY VENOOCCLUSIVE DISEASE TREATED WITH SILDENAFIL Chest. 130: 307S. DOI: 10.1378/chest.130.4_MeetingAbstracts.307S-a  0.01
1991 Wirta RW, Golbranson FL, Mason R, Calvo K. Analysis of below-knee suspension systems: effect on gait. Journal of Rehabilitation Research and Development. 27: 385-96. PMID 2089149 DOI: 10.1682/JRRD.1990.10.0385  0.01
1991 Wirta RW, Mason R, Calvo K, Golbranson FL. Effect on gait using various prosthetic ankle-foot devices. Journal of Rehabilitation Research and Development. 28: 13-24. PMID 2066867 DOI: 10.1682/JRRD.1991.04.0013  0.01
Hide low-probability matches.